Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion,...
N2:PHMR
N2:BIODRG
N2:BLR
N2:CMPNY
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:HECA
N2:HFAC
N2:HFAC1
N2:INFDIS
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBHEA
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:RESPIR
N2:US
N2:VACCIN
Pfizer posts surprise 4th quarter profit, but key products miss on sales
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
N2:BKRT
N2:CASE1
N2:CLJ
N2:GEN
N2:HEA
N2:HECA
N2:JUDIC
N2:MNGCON
N2:NAMER
N2:PHAR1
N2:PHMR
N2:SUBSAB
N2:US
McKinsey to pay $78 million in US opioid settlement with health plans
By Nate Raymond (Reuters) – Consulting firm McKinsey & Co has agreed to pay $78...
N2:ASIA
N2:BE
N2:BIOPH
N2:BL
N2:CMPNY
N2:CPROD
N2:EREP
N2:EUROP
N2:EXCLSV
N2:FR
N2:GB
N2:HEA
N2:JP
N2:MEVN
N2:MRCH
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:TOPNWS
N2:US
Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in January
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda...
N2:BLR
N2:CMPNY
N2:CNCER
N2:DRUDEV
N2:DVST
N2:HEA
N2:HECA
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:US
Johnson & Johnson forecasts as much as 6% sales growth in 2024
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth...
N2:BACT
N2:BIZ
N2:CFIN
N2:CMPNY
N2:DEAL1
N2:DVST
N2:MRG
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHMR
N2:PVE
N2:US
Blackstone explores sale of Anthos Therapeutics -sources
By David Carnevali NEW YORK (Reuters) -Private equity firm Blackstone is exploring the sale of...
N2:AMERS
N2:EPMICS
N2:FERREP
N2:HEA
N2:INFDIS
N2:PHMR
N2:PRENEW
N2:PUBHEA
N2:SEXTRA
N2:VACCIN
N2:WOMHEA
Scientists infect volunteers with Zika in hunt for vaccines, treatments
By Jennifer Rigby (Reuters) – Researchers in the United States have shown for the first...
N2:BKRT
N2:CIV
N2:CMPNY
N2:DBTR
N2:HEA
N2:HECA
N2:JUDIC
N2:MAN
N2:MTPIX
N2:NAMER
N2:PHMR
N2:PUBHEA
N2:PUBL
N2:PXP
N2:RDNOGR
N2:RDRU
N2:US
Rite Aid files for bankruptcy faced with high debt, opioid lawsuits
By Abinaya V and Dietrich Knauth (Reuters) -Debt-laden U.S. drugstore chain Rite Aid filed for...
N2:AMERS
N2:BACT
N2:BIZ
N2:CIV
N2:CLJ
N2:CMPNY
N2:DIABET
N2:DRUGEN
N2:GEN
N2:GENHLT
N2:HCPOL
N2:HEA
N2:HEAINS
N2:HECA
N2:INSR
N2:JUDIC
N2:LAW
N2:MAN
N2:MEDREG
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR
N2:PHAR08
N2:PHAR1
N2:PHMR
N2:POL
N2:PUBHEA
N2:PUBL
N2:REGS
N2:US
N2:USACT
US judge refuses to block Medicare from negotiating drug prices
By Brendan Pierson (Reuters) -The U.S. government’s Medicare health insurance program can begin negotiating prices...
N2:ARTI
N2:CH
N2:CMPNY
N2:DE
N2:DRUDEV
N2:EREP
N2:EUROP
N2:HEA
N2:HECA
N2:INSGHT
N2:ITEC
N2:MEDREG
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR
N2:PHAR1
N2:PHMR
N2:PUBL
N2:SCI
N2:TECH
N2:US
Big Pharma bets on AI to speed up clinical trials
By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...